Prognostic molecular markers in pediatric liver disease - Are there any?

Jon Nielsen, Vibeke Brix Christensen, Lise Borgwardt, Allan Rasmussen, Olga Østrup, Mette Skalshøi Kjær


Pediatric liver disease (PLD) is a major cause of severe morbidity and prolonged hospitalizations in children. Stratifying patients in terms of prognosis remains challenging. The limited knowledge about molecular mechanisms causing and accompanying PLD remains the main obstacle in a search for reliable prognostic biomarkers. A systematic search of MEDLINE via PubMed and Embase via OVID was conducted on studies published between August 2007 and August 2017. Molecular markers with a prognostic potential in terms of survival, need for liver transplantation or disease progression/regression were selected. In general, identified studies were single center smaller case-control studies or case series with a low level of evidence and a high risk of bias. Only 23 studies comprising 898 patients could be included, mostly focusing on biliary atresia, non-alcoholic fatty liver disease, viral hepatitis, and LT; and markers related to morphogenesis and fibrosis. Furthermore, molecular markers in metabolic pathways and inflammation shown to be relevant, however requiring further validation. Hence, further biological and clinical studies are needed to gain greater molecular insight into PLD.

TidsskriftBiochimica et Biophysica Acta - Molecular Basis of Disease
Udgave nummer3
Sider (fra-til)577-586
Antal sider10
StatusUdgivet - 1 mar. 2019


Dyk ned i forskningsemnerne om 'Prognostic molecular markers in pediatric liver disease - Are there any?'. Sammen danner de et unikt fingeraftryk.